25 related articles for article (PubMed ID: 2403813)
1. Development and Testing of Thrombolytics in Stroke.
Nikitin D; Choi S; Mican J; Toul M; Ryu WS; Damborsky J; Mikulik R; Kim DE
J Stroke; 2021 Jan; 23(1):12-36. PubMed ID: 33600700
[TBL] [Abstract][Full Text] [Related]
2. Modeling protein folding in vivo.
Sorokina I; Mushegian A
Biol Direct; 2018 Jul; 13(1):13. PubMed ID: 29980221
[TBL] [Abstract][Full Text] [Related]
3. Insights from bacterial subtilases into the mechanisms of intramolecular chaperone-mediated activation of furin.
Shinde U; Thomas G
Methods Mol Biol; 2011; 768():59-106. PubMed ID: 21805238
[TBL] [Abstract][Full Text] [Related]
4. Synonymous mutations and ribosome stalling can lead to altered folding pathways and distinct minima.
Tsai CJ; Sauna ZE; Kimchi-Sarfaty C; Ambudkar SV; Gottesman MM; Nussinov R
J Mol Biol; 2008 Nov; 383(2):281-91. PubMed ID: 18722384
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing between sequential and nonsequentially folded proteins: implications for folding and misfolding.
Tsai CJ; Maizel JV; Nussinov R
Protein Sci; 1999 Aug; 8(8):1591-604. PubMed ID: 10452603
[TBL] [Abstract][Full Text] [Related]
6. Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.
Gootz TD; Zaniewski RP; Haskell SL; Kaczmarek FS; Maurice AE
Antimicrob Agents Chemother; 1999 Aug; 43(8):1845-55. PubMed ID: 10428901
[TBL] [Abstract][Full Text] [Related]
7. Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1.
Madison EL; Goldsmith EJ; Gerard RD; Gething MJ; Sambrook JF; Bassel-Duby RS
Proc Natl Acad Sci U S A; 1990 May; 87(9):3530-3. PubMed ID: 2110366
[TBL] [Abstract][Full Text] [Related]
8. Recombinant plasminogen activator inhibitor type 1: a review of structural, functional, and biological aspects.
Reilly TM; Mousa SA; Seetharam R; Racanelli AL
Blood Coagul Fibrinolysis; 1994 Feb; 5(1):73-81. PubMed ID: 8180342
[TBL] [Abstract][Full Text] [Related]
9. The latent tendencies of PAI-1.
Sprang SR
Trends Biochem Sci; 1992 Feb; 17(2):49-50. PubMed ID: 1566324
[No Abstract] [Full Text] [Related]
10. Expression of human plasminogen activator inhibitor type-1 (PAI-1) in Escherichia coli as a soluble protein comprised of active and latent forms. Isolation and crystallization of latent PAI-1.
Franke AE; Danley DE; Kaczmarek FS; Hawrylik SJ; Gerard RD; Lee SE; Geoghegan KF
Biochim Biophys Acta; 1990 Jan; 1037(1):16-23. PubMed ID: 2403813
[TBL] [Abstract][Full Text] [Related]
11. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
Lawrence D; Strandberg L; Grundström T; Ny T
Eur J Biochem; 1989 Dec; 186(3):523-33. PubMed ID: 2514093
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of recombinant plasminogen activator inhibitor-1 from Escherichia coli.
Reilly TM; Seetharam R; Duke JL; Davis GL; Pierce SK; Walton HL; Kingsley D; Sisk WP
J Biol Chem; 1990 Jun; 265(16):9570-4. PubMed ID: 2188980
[TBL] [Abstract][Full Text] [Related]
13. Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family.
Pannekoek H; Veerman H; Lambers H; Diergaarde P; Verweij CL; van Zonneveld AJ; van Mourik JA
EMBO J; 1986 Oct; 5(10):2539-44. PubMed ID: 2430793
[TBL] [Abstract][Full Text] [Related]
14. High-level synthesis of biologically active human plasminogen activator inhibitor type 1 (PAI-1) in Escherichia coli.
Sisk WP; Davis GL; Kingsley D; Chiu AT; Reilly TM
Gene; 1990 Dec; 96(2):305-9. PubMed ID: 2269442
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of active and latent forms of recombinant plasminogen activator inhibitor 1 produced in Escherichia coli.
Seetharam R; Dwivedi AM; Duke JL; Hayman AC; Walton HL; Huckins NR; Kamerkar SM; Corman JI; Woodeshick RW; Wilk RR
Biochemistry; 1992 Oct; 31(41):9877-82. PubMed ID: 1382596
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
